Is incidentally detected prostate cancer in patients undergoing radical cystoprostatectomy clinically significant?

American Journal of Clinical Pathology

Volumn 131, Issue 2, 2009, Pages 279-283

  Mazzucchelli, Roberta ^a   Barbisan, Francesca ^a   Scarpelli, Marina ^a   Lopez Beltran, Antonio ^b   Van Der Kwast, Theodorus H ^c   Cheng, Liang ^d   Montironi, Rodolfo ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d INDIANA UNIVERSITY   (United States)

Author keywords

Cystoprostatectomy; Incidental prostate cancer; Prostate cancer

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER INVASION; CANCER SIZE; CYSTECTOMY; GLEASON SCORE; HUMAN; HUMAN TISSUE; INCIDENTAL FINDING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; ADENOCARCINOMA; MIDDLE AGED; PROGNOSIS; PROSTATE TUMOR; RISK ASSESSMENT;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CYSTECTOMY; HUMANS; INCIDENTAL FINDINGS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK ASSESSMENT;

EID: 58849085131     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCP4OCYZBAN9TJU     Document Type: Article

References (41)

1. Montironi R Mazzucchelli R Santinelli A, et al. Incidentally detected prostate cancer in cystoprostatectomies: pathological and morphometric comparison with clinically detected cancer in totally embedded specimens. Hum Pathol. 2005;36:646-654.
2. Montironi R Mazzucchelli R Barbisan F, et al. HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected androgen-dependent and androgen-independent cancer. Hum Pathol. 2006;37:1137-1144.
3. Santinelli A, Mazzucchelli R, Barbisan F, et al. α-Methylacyl coenzyme A racemase, Ki-67, and topoisomerase IIα in cystoprostatectomies with incidental prostate cancer. Am J Clin Pathol. 2007;128:657-666.
4. Barbisan F, Mazzucchelli R, Santinelli A, et al. Overexpression of ELAV-like protein HuR is associated with increased COX-2 expression in atrophy, high-grade prostatic intraepithelial neoplasia, and incidental prostate cancer in cystoprostatectomies [published online ahead of print April 30, 2008]. Eur Urol.
5. Hayat MJ, Howlader N, Reichman ME, et al. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist. 2007;12:20-37.
6. Breslow N, Chan CW, Dhom G, et al. Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyon, France. Int Cancer. 1977;20:680-688.
7. Stamey TA, Freiha FS, McNeal JE, et al. Localized prostate cancer: relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer. 1993;71:933-938.
8. Esgueva R, Lorente JA, Mojal S, et al. Incidental prostatic adenocarcinoma in radical cystoprostatectomy specimens: the impact of embedding protocols [abstract]. Mod Pathol. 2008; 21(suppl 1):155A.
9. Montironi R, Mazzucchelli R, van der Kwast T. Morphological assessment of radical prostatectomy specimens: a protocol with clinical relevance. Virchows Arch. 2003;442:211-217.
10. Sobin LH, Wittekind C. Urologic tumours: prostate. In: Sobin LH, Wittekind C; for the International Union Against Cancer (UICC), eds. TNM Classification of Malignant Tumours. 6th ed. New York, NY: Wiley-Liss; 2002:184-187.
11. Epstein JI, Allsbrook WC Jr, Amin MB, et al; ISUP Grading Committee. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol. 2005;29:1228-1242.
12. Lopez-Beltran A, Mikuz G, Luque RJ, et al. Current practice of Gleason grading of prostate carcinoma. Virchows Arch. 2006;448:111-118.
13. Scattoni V, Montironi R, Mazzucchelli R, et al. Pathological changes of high-grade prostatic intraepithelial neoplasia and prostate cancer after monotherapy with bicalutamide 150 mg. BJU Int. 2006;98:54-58.
14. Epstein JI, Walsh PC, Carmichael M, et al. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA. 1994;271:368-374.
15. Autorino R, Di Lorenzo G, Damiano R, et al. Pathology of the prostate in radical cystectomy specimens: a critical review [published online ahead of print August 28, 2008]. Surg Oncol. In press.
16. Damiano R, Di Lorenzo G, Cantiello F, et al. Clinicopathologic features of prostate adenocarcinoma incidentally discovered at the time of radical cystectomy: an evidence-based analysis. Eur Urol. 2007;52:648-657.
17. Cindolo L, Benincasa G, Autorino R, et al. Prevalence of silent prostatic adenocarcinoma in 165 patients undergone cystoprostatectomy: a retrospective study. Oncol Rep. 2001;8:269-271.
18. Conrad S, Hautmann SH, Henke RP, et al. Detection and characterization of early prostate cancer by six systematic biopsies and fine needle aspiration cytology in prostates from bladder cancer patients. Eur Urol. 2001;39(suppl 4):25-29.
19. Montie JE, Wood DP Jr, Pontes JE, et al. Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer. Cancer. 1989;63:381-385.
20. Revelo MP, Cookson MS, Chang SS, et al. Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery. J Urol. 2004;171:646-651.
21. Yang CR, Ou YC, Ho HC, et al. Unsuspected prostate carcinoma and prostatic intraepithelial neoplasm in Taiwanese patients undergoing cystoprostatectomy. Mol Urol. 1999;3:33-39.
22. Ruffion A, Manel A, Massoud W, et al. Preservation of prostate during radical cystectomy: evaluation of prevalence of prostate cancer associated with bladder cancer. Urology. 2005;65:703-707.
23. Abbas F, Hochberg D, Civantos F, et al. Incidental prostatic adenocarcinoma in patients undergoing radical cystoprostatectomy for bladder cancer. Eur Urol. 1996;30:322-326.
24. Moutzouris G, Barbatis C, Plastiras D, et al. Incidence and histological findings of unsuspected prostatic adenocarcinoma in radical cystoprostatectomy for transitional cell carcinoma of the bladder. Scand J Urol Nephrol. 1999;33:27-30.
25. Lee SH, Chang PL, Chen SM, et al. Synchronous primary carcinomas of the bladder and prostate. Asian J Androl. 2006;8:357-359.
26. Hsing AW, Tsao L, Devesa SS. International trends and patterns of prostate cancer incidence and mortality. Int J Cancer. 2000;85:60-67.
27. Abdelhady M, Abusamra A, Pautler SE, et al. Clinically significant prostate cancer found incidentally in radical cystoprostatectomy specimens. BJU Int. 2007;99:326-329.
28. Aydin O, Cosar EF, Varinli S, et al. Prostatic intraepithelial neoplasia in prostate specimens: frequency, significance and relationship to the sampling of the specimen (a retrospective study of 121 cases). Int Urol Nephrol. 1999;31:687-697.
29. Delongchamps NB, Mao K, Theng H, et al. Outcome of patients with fortuitous prostate cancer after radical cystoprostatectomy for bladder cancer. Eur Urol. 2005;48:946-950.
30. Hosseini SY, Danesh AK, Parvin M, et al. Incidental prostatic adenocarcinoma in patients with PSA less than 4 ng/mL undergoing radical cystoprostatectomy for bladder cancer in Iranian men. Int Braz J Urol. 2007;33:167-173.
31. Kabalin JN, McNeal JE, Price HM, et al. Unsuspected adenocarcinoma of the prostate in patients undergoing cystoprostatectomy for other causes: incidence, histology and morphometric observations. J Urol. 1989;141:1091-1094.
32. Kouriefs C, Fazili T, Masood S, et al. Incidentally detected prostate cancer in cystoprostatectomy specimens. Urol Int. 2005;75:213-216.
33. Prange W, Erbersdobler A, Hammerer P, et al. High-grade prostatic intraepithelial neoplasia in cystoprostatectomy specimens. Eur Urol. 2001;39(suppl 4):30-31.
34. Pritchett TR, Moreno J, Warner NE, et al. Unsuspected prostatic adenocarcinoma in patients who have undergone radical cystoprostatectomy for transitional cell carcinoma of the bladder. J Urol. 1988;139:1214-1216.
35. Rocco B, de Cobelli O, Leon ME, et al. Sensitivity and detection rate of a 12-core trans-perineal prostate biopsy: preliminary report. Eur Urol. 2006;49:827-833.
36. Ward JF, Bartsch G, Sebo TJ, et al. Pathologic characterization of prostate cancers with a very low serum prostate specific antigen (0-2 ng/mL) incidental to cystoprostatectomy: is PSA a useful indicator of clinical significance? Urol Oncol. 2004;22:40-47.
37. Weizer AZ, Shah RB, Lee CT, et al. Evaluation of the prostate peripheral zone/capsule in patients undergoing radical cystoprostatectomy: defining risk with prostate capsule sparing cystectomy. Urol Oncol. 2007;25:460-464.
38. Winfield HN, Reddy PK, Lange PH. Coexisting adenocarcinoma of prostate in patients undergoing cystoprostatectomy for bladder cancer. Urology. 1987;30:100-101.
39. Winkler MH, Livni N, Mannion EM, et al. Characteristics of incidental prostatic adenocarcinoma in contemporary radical cystoprostatectomy specimens. BJU Int. 2007;99:554-558.
40. Androulakakis PA, Schneider HM, Jacobi GH, et al. Coincident vesical transitional cell carcinoma and prostatic carcinoma: clinical features and treatment. Br J Urol. 1986;58:153-156.
41. Konski A, Rubin P, DiSantangnese PA, et al. Simultaneous presentation of adenocarcinoma of prostate and transitional cell carcinoma of bladder. Urology. 1991;37:202-206.